Lack of a chondroprotective effect of cyclooxygenase 2 inhibition in a surgically induced model of osteoarthritis in mice

Arthritis and Rheumatism

Volumn 64, Issue 1, 2012, Pages 198-203

  Fukai, Atsushi ^a   Kamekura, Satoru ^a   Chikazu, Daichi ^a   Nakagawa, Takumi ^a   Hirata, Makoto ^a   Saito, Taku ^a   Hosaka, Yoko ^a   Ikeda, Toshiyuki ^a   Nakamura, Kozo ^a   Chung, Ung Il ^a   Kawaguchi, Hiroshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; PROSTAGLANDIN E SYNTHASE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARTILAGE; CARTILAGE DEGENERATION; CHONDROPROTECTION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; ENZYME INHIBITION; GENE INACTIVATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JOINT INSTABILITY; KNEE OSTEOARTHRITIS; MOUSE; NONHUMAN; OSTEOPHYTE; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TIBIA; TOTAL KNEE REPLACEMENT;

ADMINISTRATION, ORAL; ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHROPLASTY, REPLACEMENT, KNEE; CARTILAGE, ARTICULAR; CHONDROCYTES; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; FEMALE; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; JOINT INSTABILITY; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSOMES; OSTEOARTHRITIS; OSTEOARTHRITIS, KNEE; PYRAZOLES; STIFLE; SULFONAMIDES; TIBIA;

EID: 84855261140     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.33324     Document Type: Article

References (21)

1. 2 modulates cartilage proteoglycan degradation in human osteoarthritis explants. Arthritis Rheum 2002; 46: 1789-803. (Pubitemid 34774511)
2. 2-biosynthetic pathway. Prog Lipid Res 2004; 43: 3-35. (Pubitemid 37433865)
3. Ding C,. Do NSAIDs affect the progression of osteoarthritis? Inflammation 2002; 26: 139-42. (Pubitemid 34596973)
4. Valdes AM, Loughlin J, Timms KM, van Meurs JJ, Southam L, Wilson SG, et al. Genome-wide association scan identifies a prostaglandin-endoperoxide synthase 2 variant involved in risk of knee osteoarthritis. Am J Hum Genet 2008; 82: 1231-40.
5. Mastbergen SC, Jansen NW, Bijlsma JW, Lafeber FP,. Differential direct effects of cyclo-oxygenase-1/2 inhibition on proteoglycan turnover of human osteoarthritic cartilage: an in vitro study. Arthritis Res Ther 2006; 8: R2.
6. De Boer TN, Huisman AM, Polak AA, Niehoff AG, van Rinsum AC, Saris D, et al. The chondroprotective effect of selective COX-2 inhibition in osteoarthritis: ex vivo evaluation of human cartilage tissue after in vivo treatment. Osteoarthritis Cartilage 2009; 17: 482-8.
7. Mastbergen SC, Marijnissen AC, Vianen ME, Zoer B, van Roermund PM, Bijlsma JW, et al. Inhibition of COX-2 by celecoxib in the canine groove model of osteoarthritis. Rheumatology (Oxford) 2006; 45: 405-13.
8. De Boer TN, Mastbergen SC, Huisman AM, Polak AA, Bijlsma JW, Lafeber FP,. Lack of disease modifying activity of celecoxib in end-stage OA: a randomized controlled trial. Osteoarthritis Cartilage 2010; 18 SUPPL. 2: S145.
9. Kawaguchi H,. Endochondral ossification signals in cartilage degradation during osteoarthritis progression in experimental mouse models. Mol Cells 2008; 25: 1-6. (Pubitemid 351611832)
10. Yu Y, Cheng Y, Fan J, Chen XS, Klein-Szanto A, FitzGerald GA, et al. Differential impact of prostaglandin H synthase 1 knockdown on platelets and parturition. J Clin Invest 2005; 115: 986-95. (Pubitemid 40489403)
11. Dinchuk JE, Car BD, Focht RJ, Johnston JJ, Jaffee BD, Covington MB, et al. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature 1995; 378: 406-9.
12. Kamekura S, Hoshi K, Shimoaka T, Chung U, Chikuda H, Yamada T, et al. Osteoarthritis development in novel experimental mouse models induced by knee joint instability. Osteoarthritis Cartilage 2005; 13: 632-41. (Pubitemid 40867863)
13. Pritzker KP, Gay S, Jimenez SA, Ostergaard K, Pelletier JP, Revell PA, et al. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage 2006; 14: 13-29. (Pubitemid 43034086)
14. Yamakawa K, Kamekura S, Kawamura N, Saegusa M, Kamei D, Murakami M, et al. Association of microsomal prostaglandin E synthase 1 deficiency with impaired fracture healing, but not with bone loss or osteoarthritis, in mouse models of skeletal disorders. Arthritis Rheum 2008; 58: 172-83.
15. Manabe N, Oda H, Nakamura K, Kuga Y, Uchida S, Kawaguchi H,. Involvement of fibroblast growth factor-2 in joint destruction of rheumatoid arthritis patients. Rheumatology (Oxford) 1999; 38: 714-20. (Pubitemid 29507386)
16. Hirata M, Kugimiya F, Fukai A, Ohba S, Kawamura N, Ogasawara T, et al. C/EBPβ promotes transition from proliferation to hypertrophic differentiation of chondrocytes through transactivation of p57. PLoS One 2009; 4: e4543.
17. Zhang X, Schwarz EM, Young DA, Puzas JE, Rosier RN, O'Keefe RJ,. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 2002; 109: 1405-15. (Pubitemid 34596166)
18. Gerwin N, Bendele AM, Glasson S, Carlson CS,. The OARSI histopathology initiative-recommendations for histological assessments of osteoarthritis in the rat. Osteoarthritis Cartilage 2010; 18 SUPPL. 3: S24-34.
19. Kraus VB, Huebner JL, DeGroot J, Bendele A,. The OARSI histopathology initiative-recommendations for histological assessments of osteoarthritis in the guinea pig. Osteoarthritis Cartilage 2010; 18 SUPPL. 3: S35-52.
20. Bove SE, Laemont KD, Brooker RM, Osborn MN, Sanchez BM, Guzman RE, et al. Surgically induced osteoarthritis in the rat results in the development of both osteoarthritis-like joint pain and secondary hyperalgesia. Osteoarthritis Cartilage 2006; 14: 1041-8. (Pubitemid 44309423)
21. Ferland CE, Laverty S, Beaudry F, Vachon P,. Gait analysis and pain response of two rodent models of osteoarthritis. Pharmacol Biochem Behav 2011; 97: 603-10.